Ebola Vaccine to be Tested by J (and) J in January

Johnson (and) Johnson has announced that it will spend up to (Dollar) 200 million to speed up and expand its Ebola vaccine program. Testing of the vaccine is slated to begin in January. Johnson (and) Johnson said its unit Janssen Pharmaceutical Companies was closely working with the World Health Organization, the National Institute of Allergy and Infectious Diseases, as well as other key stakeholders, governments and public health authorities on the program. The proposed ...